Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_1961
http://purl.obolibrary.org/obo/dinto_1961
|
|---|---|
| Preferred Name | 3-oxo-5-beta-steroid 4-dehydrogenase |
| Synonyms |
aldo-keto reductase family 1 member d1
delta(4)-3-ketosteroid 5-beta-reductase
delta(4)-3-oxosteroid 5-beta-reductase
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | 3-oxo-5-beta-steroid 4-dehydrogenase
|
|---|---|
| label | 3-oxo-5-beta-steroid 4-dehydrogenase
|
| Definition | Efficiently catalyzes the reduction of progesterone, androstenedione, 17-alpha-hydroxyprogesterone and testosterone to 5-beta-reduced metabolites. The bile acid intermediates 7- alpha,12-alpha-dihydroxy-4-cholesten-3-one and 7-alpha-hydroxy-4- cholesten-3-one can also act as substrates
|
| type | |
| is inhibited by | |
| Synonym |
aldo-keto reductase family 1 member d1
delta(4)-3-ketosteroid 5-beta-reductase
delta(4)-3-oxosteroid 5-beta-reductase
|
| OrganismClass | human
|
| xref |
UniProt ID:P51857
DrugBank:6105
|
| definition source | DrugBank Database
|
| prefixIRI | obo2:dinto_1961
|
| related with | |
| is pharmacological target of | |
| Gene | akr1d1
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |